C25.3
Malignant neoplasm of pancreatic duct
Clinical Classification Guidelines
Medical Intelligence & Overview
A malignant neoplasm of the pancreatic duct, categorized under ICD-10 code C25.3, refers to a type of pancreatic cancer that originates in the duct responsible for carrying digestive enzymes from the pancreas to the small intestine. This form of cancer is known for its aggressive nature and tendency to be diagnosed at advanced stages due to subtle early symptoms. The pancreas plays a vital role in digestion and blood sugar regulation, and when affected by cancer, it can significantly impact overall health. Early detection and understanding of this condition can be crucial for managing its progression.
Causes & Symptoms
Clinical Causes: Genetic factors and family history of pancreatic cancer Chronic pancreatitis or long-standing inflammation of the pancreas Lifestyle factors such as smoking, obesity, and a high-fat diet Diabetes or insulin resistance Certain inherited genetic mutations and syndromes Exposure to environmental toxins and chemicals
Key Symptoms: Jaundice (yellowing of the skin and eyes) Unexpected weight loss and loss of appetite Upper abdominal pain that may radiate to the back Nausea and vomiting Dark urine and pale stools New-onset diabetes or worsening blood sugar control Digestive difficulties such as indigestion or fatty stools
Diagnostic & Treatment
Diagnosis Path: Imaging tests such as ultrasound, computed tomography (CT) scans, magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS) to visualize the pancreas Endoscopic procedures like endoscopic retrograde cholangiopancreatography (ERCP) for tissue sampling Biopsy to confirm cancerous cells Blood tests, including tumor markers like CA 19-9 Assessment of liver function and other organ involvement
Treatment Protocols: Surgical resection, such as the Whipple procedure, if the tumor is localized and operable Chemotherapy to target cancer cells and slow disease progression Radiation therapy to reduce tumor size and alleviate symptoms Targeted therapy and immunotherapy in select cases Palliative care focused on symptom relief and quality of life improvements
Clinical Advice & FAQs
Billing Guidance
Is C25.3 a billable ICD-10 code?
Yes, C25.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C25.3?
Clinical documentation must specify the nature of Malignant neoplasm of pancreatic duct and any associated comorbidities for accurate reporting.
Cite this Clinical Reference